Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIV201 in Refractory Ascites
NCT04112199Phase 2Terminated
- Sponsor
- BioVie
- Start
- Jun 2021
- Primary completion
- May 2023
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of BIV201 in ascites, sponsored by BioVie. Started Jun 2021; status: terminated.
02
Drugs
BIV201
03
Conditions
ascites
Beyond the preview
Go deeper on NCT04112199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04112199.